PharmaCyte Biotech Inc (PMCB)

[esusun]

I disagree , I think PMCB is undervalued , and I think that
getting approved IND to run a pivotal trial will move us up closer to a $250mm market cap ( or $0.25 / sh ). Not to mention , approved IND would trigger ( hopefully) a milestone payment from a partner . This will expose whether we do or do Not have a partner to fund trials . if we get a $40mm milestone payment , and have a legit bigger P partner , then BOOM , I see $500mm market cap . And as the human trial progresses , there will be lots of investor interest .
---------------------------------------------------------------
look at living cell tech ( LVCLY ) , in 2017 they were running a very small human trial for cell therapy for Parkinson's , LVCLY traded up to nearly $2.00 / sh during this tiny trial ...... the trial results we a disappointment , and the stock immediately tanked down to $0.20 ........

so here we ( PMCB ) sits at $0.07 ...... if our stock behaves similar to LVCLY , then .07 may become $0.70 .

I would be very happy to see that .
----------------------------------------------------------------
Also , note that PMCB stock has been controlled by some shorts sellers , and or FAKE volume .. YOU can see now that the daily FAKE volume has dried up